- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
MMTX
EBS
Week ended 07 Aug 2026
Weekly Investor Report
MindMaze Therapeutics Holding SA · Healthcare · Biotechnology
Latest close
0.24 CHF
20.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -50.6% below the Trend Line and sits at 3.1% of its 52-week range. The latest completed week returned 20.9%, after a 38.7% four-week move. The latest news-sentiment score is 50/100.
Setup score
43
out of 100
Latest Close
0.24 CHF
7 Aug 2026
1W Return
20.9%
latest completed week
4W Return
38.7%
short-term follow-through
12W Return
-43.5%
quarterly tape
Trend Breadth
0.0%
0 of 34 weeks active
Volume Ratio
1.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 27.09% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
20.9%
Latest completed week; four-week move 38.7%.
Indicator stack
0/58
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 27.09%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -50.6% below the Trend Line and sits at 3.1% of its 52-week range. The latest completed week returned 20.9%, after a 38.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.03
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 38.7% over four weeks, -43.5% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.27Latest activity-pressure read.
Pressure change34.9%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-91.9%Distance below the 52-week high.
13-week volatility14.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 2618 weeks finished lower.
Best week+26.2%Week of 31 Jul.
Worst week-26.2%Week of 27 Feb.
Latest week+20.9%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains1
Flat weeks0
Modest losses3
Sharp losses15
Recent vol14.8%13-week weekly-return volatility.
Base vol12.6%52-week weekly-return volatility.
Up/down split10/23Count of positive and negative weeks in the 52-week window.
Average skew10.5% / -12.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Healthcare
4-week rank1 / 40
Group average2.0%
Trend breadth52.5%
Trend52.5%active weekly trend signals
MD62.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryCH Biotechnology
4-week rank1 / 11
Group average2.2%
Trend breadth36.4%
Trend36.4%active weekly trend signals
MD36.4%positive activity pressure
RS36.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape32/100
Trend, activity pressure, participation, and risk combine to a 32/100 tape read.
Indicator analysis19/100Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 27.09%Next-week expectancy is negative with a 27.09% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
MindMaze Therapeutics Announces Results of Annual General Meeting - boerse.de Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.24 CHF | 20.9% | 0.49 CHF | 0.66 CHF | 0.27 | - | 8.5M | Off |
| 31 Jul 2026 | 0.20 CHF | 26.2% | 0.53 CHF | 0.67 CHF | 0.25 | - | 7.6M | Off |
| 24 Jul 2026 | 0.16 CHF | -2.0% | 0.59 CHF | 0.69 CHF | 0.22 | - | 3.4M | Off |
| 17 Jul 2026 | 0.16 CHF | -7.2% | 0.66 CHF | 0.70 CHF | 0.24 | - | 5.5M | Off |
| 10 Jul 2026 | 0.17 CHF | -16.8% | 0.72 CHF | 0.72 CHF | 0.20 | - | 7.6M | Off |
| 3 Jul 2026 | 0.21 CHF | -3.5% | - | 0.74 CHF | 0.12 | - | 610.8K | Off |
| 26 Jun 2026 | 0.22 CHF | 0.5% | - | 0.76 CHF | - | - | 1.8M | Off |
| 19 Jun 2026 | 0.22 CHF | -22.9% | - | 0.78 CHF | - | - | 2.2M | Off |
| 12 Jun 2026 | 0.28 CHF | -18.7% | - | 0.80 CHF | - | - | 2.1M | Off |
| 5 Jun 2026 | 0.34 CHF | -7.9% | - | 0.82 CHF | - | - | 1.5M | Off |
| 29 May 2026 | 0.37 CHF | -16.1% | - | 0.84 CHF | - | - | 7.8M | Off |
| 22 May 2026 | 0.45 CHF | 4.3% | - | 0.86 CHF | - | - | 7.2M | Off |
| 15 May 2026 | 0.43 CHF | 15.3% | - | 0.88 CHF | - | - | 4.0M | Off |
| 8 May 2026 | 0.37 CHF | 15.3% | - | 0.91 CHF | - | - | 7.6M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.